EDGE: A Phase 3 study evaluating once versus twice daily dosing of eliglustat in patients with Gaucher disease type 1: interim results from the lead-in-period

Saved in:
Bibliographic Details
Published in:Molecular genetics and metabolism 2014-02, Vol.111 (2), p.S30-S30
Main Authors: Charrow, Joel, Ida, Hiroyuki, Hollak, Carla, Amato, Dominick, Cravo, Renata, Kawaguchi, Osamu, Xue, Yong
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1096-7192
1096-7206
DOI:10.1016/j.ymgme.2013.12.053